Sarah Bartlett

NPI: 1750945234
Total Payments
$11,696
2024 Payments
$4,483
Companies
42
Transactions
351
Medicare Patients
5,272
Medicare Billing
$237,758

Payment Breakdown by Category

Food & Beverage$9,971 (85.3%)
Travel$696.06 (6.0%)
Education$630.92 (5.4%)
Consulting$397.50 (3.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,971 340 85.3%
Travel and Lodging $696.06 3 6.0%
Education $630.92 7 5.4%
Consulting Fee $397.50 1 3.4%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $1,720 46 $0 (2024)
Axonics, Inc. $1,442 13 $0 (2024)
Sumitomo Pharma America, Inc. $849.49 39 $0 (2024)
Dendreon Pharmaceuticals LLC $816.59 20 $0 (2024)
Astellas Pharma US Inc $750.35 19 $0 (2024)
Endo Pharmaceuticals Inc. $695.67 36 $0 (2024)
PFIZER INC. $675.46 26 $0 (2024)
Myriad Genetic Laboratories, Inc. $585.99 10 $0 (2024)
Janssen Scientific Affairs, LLC $493.02 2 $0 (2023)
GENZYME CORPORATION $483.74 12 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,483 109 Axonics, Inc. ($1,271)
2023 $3,524 105 Janssen Biotech, Inc. ($603.18)
2022 $2,656 96 Janssen Biotech, Inc. ($348.78)
2021 $1,032 41 Clarus Therapeutics Inc. ($220.76)

All Payment Transactions

351 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/19/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $19.44 General
Category: ONCOLOGY
12/19/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $17.96 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
12/18/2024 Azurity Pharmaceuticals, Inc. ADTHYZA (Drug) Food and Beverage In-kind items and services $19.95 General
Category: ENDOCRINOLOGY
12/17/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $0.38 General
Category: UROLOGY
12/16/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $14.53 General
Category: UROLOGY
12/13/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $22.38 General
Category: UROLOGY
12/11/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $20.55 General
Category: UROLOGY
11/22/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $18.12 General
Category: ONCOLOGY
11/21/2024 Axonics, Inc. Bulkamid (Device), Axonics Food and Beverage In-kind items and services $140.55 General
Category: Urology
11/20/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $18.30 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
11/18/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $130.35 General
Category: UROLOGY
11/14/2024 Myriad Genetic Laboratories, Inc. MYRISK (Device) Food and Beverage In-kind items and services $93.95 General
Category: ONCOLOGY
11/14/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $18.93 General
Category: UROLOGY
11/11/2024 SUN PHARMACEUTICAL INDUSTRIES INC. YONSA (Drug) Food and Beverage In-kind items and services $25.23 General
Category: Oncology
11/07/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $26.10 General
Category: UROLOGY
11/07/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $21.35 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
10/30/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $20.83 General
Category: UROLOGY
10/24/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $27.21 General
Category: ONCOLOGY
10/15/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $20.85 General
Category: Sacral Nerve Stimulation
09/30/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $23.59 General
Category: UROLOGY
09/26/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $28.53 General
Category: Oncology
09/24/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $128.39 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
09/24/2024 Tempus AI, Inc Food and Beverage In-kind items and services $18.75 General
09/19/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $16.65 General
Category: UROLOGY
09/18/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $10.19 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 21 1,298 1,875 $282,035 $75,637
2022 27 1,985 2,582 $281,168 $83,361
2021 26 1,137 1,315 $152,184 $47,195
2020 18 852 981 $103,440 $31,565
Total Patients
5,272
Total Services
6,753
Medicare Billing
$237,758
Procedure Codes
92

All Medicare Procedures & Services

92 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2023 27 186 $117,924 $25,034 21.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 207 307 $67,665 $21,514 31.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 116 133 $18,881 $7,194 38.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 47 47 $16,620 $4,235 25.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 71 83 $6,477 $2,443 37.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 21 22 $4,652 $1,888 40.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 27 27 $6,210 $1,783 28.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 14 14 $4,381 $1,604 36.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 17 18 $4,500 $1,573 35.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 24 30 $3,600 $1,569 43.6%
82570 Creatinine level to test for kidney function or muscle injury Office 2023 203 286 $5,434 $1,448 26.6%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 130 170 $7,413 $1,226 16.5%
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 28 49 $4,312 $1,006 23.3%
81003 Automated urinalysis test Office 2023 273 401 $3,663 $882.21 24.1%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 19 20 $2,000 $655.00 32.8%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 14 14 $2,230 $611.14 27.4%
51702 Simple insertion of temporary bladder tube Office 2023 13 14 $2,830 $477.64 16.9%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 11 13 $468.00 $195.30 41.7%
74018 X-ray of abdomen, 1 view Office 2023 12 12 $612.00 $132.43 21.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 13 18 $1,063 $111.00 10.4%
51741 Electronic assessment of bladder emptying Office 2023 11 11 $1,100 $55.06 5.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 316 395 $84,986 $28,232 33.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 166 204 $27,324 $10,250 37.5%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2022 17 69 $43,956 $9,284 21.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 74 74 $26,642 $7,820 29.4%

About Sarah Bartlett

Sarah Bartlett is a Adult Health healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2019. The National Provider Identifier (NPI) number assigned to this provider is 1750945234.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Bartlett has received a total of $11,696 in payments from pharmaceutical and medical device companies, with $4,483 received in 2024. These payments were reported across 351 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,971).

As a Medicare-enrolled provider, Bartlett has provided services to 5,272 Medicare beneficiaries, totaling 6,753 services with total Medicare billing of $237,758. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.

Practice Information

  • Specialty Adult Health
  • Location Cary, NC
  • Active Since 04/30/2019
  • Last Updated 08/08/2022
  • Taxonomy Code 363LA2200X
  • Entity Type Individual
  • NPI Number 1750945234

Products in Payments

  • ERLEADA (Drug) $1,744
  • Axonics (Device) $1,287
  • GEMTESA (Drug) $1,092
  • XIAFLEX (Biological) $918.22
  • PROVENGE (Drug) $816.59
  • XTANDI (Drug) $610.14
  • JEVTANA (Drug) $483.74
  • Xtandi (Drug) $352.89
  • MYRISK (Device) $338.56
  • Nubeqa (Drug) $300.80
  • ORGOVYX (Drug) $300.13
  • JATENZO (Drug) $220.76
  • LUPRON DEPOT (Drug) $213.69
  • ELIGARD (Drug) $199.00
  • LYNPARZA (Biological) $165.78
  • PROLARIS (Device) $155.82
  • Bulkamid (Device) $154.66
  • PYLARIFY (Drug) $153.65
  • KEYTRUDA (Biological) $141.15
  • CAMCEVI (Drug) $139.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Adult Health Doctors in Cary